Annual CFO
$219.82 M
+$434.00 K+0.20%
December 31, 2024
Summary
- As of March 12, 2025, HRMY annual cash flow from operations is $219.82 million, with the most recent change of +$434.00 thousand (+0.20%) on December 31, 2024.
- During the last 3 years, HRMY annual CFO has risen by +$121.26 million (+123.04%).
- HRMY annual CFO is now at all-time high.
Performance
HRMY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
$75.56 M
+$5.06 M+7.18%
December 31, 2024
Summary
- As of March 12, 2025, HRMY quarterly cash flow from operations is $75.56 million, with the most recent change of +$5.06 million (+7.18%) on December 31, 2024.
- Over the past year, HRMY quarterly CFO has stayed the same.
- HRMY quarterly CFO is now -1.44% below its all-time high of $76.67 million, reached on December 31, 2023.
Performance
HRMY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
$219.82 M
-$1.10 M-0.50%
December 31, 2024
Summary
- As of March 12, 2025, HRMY TTM cash flow from operations is $219.82 million, with the most recent change of -$1.10 million (-0.50%) on December 31, 2024.
- Over the past year, HRMY TTM CFO has stayed the same.
- HRMY TTM CFO is now -0.50% below its all-time high of $220.92 million, reached on September 30, 2024.
Performance
HRMY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
HRMY Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.2% | 0.0% | 0.0% |
| 3 y3 years | +123.0% | 0.0% | 0.0% |
| 5 y5 years | +391.4% | +415.0% | +391.4% |
HRMY Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.0% | -1.4% | +183.2% | -0.5% | +123.0% |
| 5 y | 5-year | at high | +391.4% | -1.4% | +383.0% | -0.5% | +340.1% |
| alltime | all time | at high | +391.4% | -1.4% | +383.0% | -0.5% | +340.1% |
Harmony Biosciences Holdings Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $219.82 M(+0.2%) | $75.56 M(+7.2%) | $219.82 M(-0.5%) |
| Sep 2024 | - | $70.50 M(+65.4%) | $220.92 M(+3.5%) |
| Jun 2024 | - | $42.62 M(+36.9%) | $213.52 M(+2.7%) |
| Mar 2024 | - | $31.14 M(-59.4%) | $207.97 M(-5.2%) |
| Dec 2023 | $219.39 M(+51.9%) | $76.67 M(+21.5%) | $219.39 M(+29.5%) |
| Sep 2023 | - | $63.10 M(+70.3%) | $169.40 M(+4.9%) |
| Jun 2023 | - | $37.06 M(-12.9%) | $161.50 M(+2.1%) |
| Mar 2023 | - | $42.56 M(+59.5%) | $158.17 M(+9.5%) |
| Dec 2022 | $144.47 M(+46.6%) | $26.68 M(-51.7%) | $144.47 M(-7.0%) |
| Sep 2022 | - | $55.20 M(+63.7%) | $155.32 M(+19.0%) |
| Jun 2022 | - | $33.73 M(+16.9%) | $130.54 M(+13.6%) |
| Mar 2022 | - | $28.85 M(-23.1%) | $114.88 M(+16.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $98.56 M(-3401.7%) | $37.53 M(+23.4%) | $98.56 M(+38.7%) |
| Sep 2021 | - | $30.42 M(+68.4%) | $71.07 M(+43.6%) |
| Jun 2021 | - | $18.07 M(+44.2%) | $49.48 M(+36.5%) |
| Mar 2021 | - | $12.53 M(+24.7%) | $36.25 M(-1314.3%) |
| Dec 2020 | -$2.98 M(-96.0%) | $10.05 M(+13.7%) | -$2.98 M(-91.9%) |
| Sep 2020 | - | $8.84 M(+82.9%) | -$37.02 M(-46.6%) |
| Jun 2020 | - | $4.83 M(-118.1%) | -$69.31 M(-24.3%) |
| Mar 2020 | - | -$26.70 M(+11.3%) | -$91.54 M(+21.4%) |
| Dec 2019 | -$75.44 M(+94.4%) | -$23.99 M(+2.3%) | -$75.44 M(+46.6%) |
| Sep 2019 | - | -$23.45 M(+34.8%) | -$51.45 M(+83.8%) |
| Jun 2019 | - | -$17.40 M(+64.2%) | -$28.00 M(+164.2%) |
| Mar 2019 | - | -$10.60 M | -$10.60 M |
| Dec 2018 | -$38.80 M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual cash flow from operations?
- What is the all time high annual CFO for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual CFO year-on-year change?
- What is Harmony Biosciences Holdings quarterly cash flow from operations?
- What is the all time high quarterly CFO for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly CFO year-on-year change?
- What is Harmony Biosciences Holdings TTM cash flow from operations?
- What is the all time high TTM CFO for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM CFO year-on-year change?
What is Harmony Biosciences Holdings annual cash flow from operations?
The current annual CFO of HRMY is $219.82 M
What is the all time high annual CFO for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual cash flow from operations is $219.82 M
What is Harmony Biosciences Holdings annual CFO year-on-year change?
Over the past year, HRMY annual cash flow from operations has changed by +$434.00 K (+0.20%)
What is Harmony Biosciences Holdings quarterly cash flow from operations?
The current quarterly CFO of HRMY is $75.56 M
What is the all time high quarterly CFO for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly cash flow from operations is $76.67 M
What is Harmony Biosciences Holdings quarterly CFO year-on-year change?
Over the past year, HRMY quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Harmony Biosciences Holdings TTM cash flow from operations?
The current TTM CFO of HRMY is $219.82 M
What is the all time high TTM CFO for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM cash flow from operations is $220.92 M
What is Harmony Biosciences Holdings TTM CFO year-on-year change?
Over the past year, HRMY TTM cash flow from operations has changed by $0.00 (0.00%)